XTL BIOPHARMACEUTICALS LTD SPONSORED ADR NE

XTL BIOPHARMACEUTICALS LTD SPONSORED ADR NE is a security (CUSIP 98386D307) tracked across SEC portfolio filings. 1 institutional managers reported positions on Form 13F as of 2025-06-30; 1 registered fund positions totaling $-24 via N-PORT as of 2026-03-31.

Summary

• Issuer: XTL BIOPHARMACEUTICALS LTD
• Class: SPONSORED ADR NE
• CUSIP: 98386D307
• Asset category: EC
• 13F holders: 1
• 13F period: 2025-06-30
• N-PORT fund positions: 1
• N-PORT value: $-24
• N-PORT report: 2026-03-31

Top institutional holders (Form 13F)

Top fund holders (N-PORT)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search